We are live on
!
Find out more
OA
Operose Advisors Portfolio holdings
AUM
$517M
Turnover
40.26%
1-Year Est. Return
24.68%
This Fund
S&P 500
This Quarter
Est. Return
+2.81%
1 Year Est. Return
+24.68%
3 Year Est. Return
+68.8%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$201M
AUM Growth
+$14M
(+7.5%)
Cap. Flow
+$10.1M
Cap. Flow
% of AUM
5%
Top 10 Holdings %
Top 10 Hldgs %
73.07%
Holding
399
New
39
Increased
61
Reduced
49
Closed
55
Avg Time Held
1
year
Top 10 Avg Time Held
1
year
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Morningstar Total Stock Market ETF
VTI
|
+$5.39M |
| 2 |
iShares International Select Dividend ETF
IDV
|
+$3.96M |
| 3 |
Vanguard High Dividend Yield ETF
VYM
|
+$3.29M |
| 4 |
Schwab International Equity ETF
SCHF
|
+$413K |
| 5 |
Artisan Partners
APAM
|
+$339K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares National Muni Bond ETF
MUB
|
+$1.83M |
| 2 |
iShares S&P Small-Cap 600 Value ETF
IJS
|
+$593K |
| 3 |
iShares Core S&P Small-Cap ETF
IJR
|
+$556K |
| 4 |
iShares MSCI Global Min Vol Factor ETF
ACWV
|
+$545K |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$369K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 86.68% |
| 2 | Financials | 4.45% |
| 3 | Technology | 3.12% |
| 4 | Consumer Discretionary | 1.57% |
| 5 | Healthcare | 1.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Salesforce
CRM
$200B
| $19.2K | 0.01% |
96
| – | – |
2021 Q4
5 quarters
|
|
227
Qualcomm
QCOM
$186B
| $19.1K | 0.01% |
150
| – | – |
2021 Q4
5 quarters
|
|
228
Otis Worldwide
OTIS
$27.1B
| $19K | 0.01% |
225
| – | – |
2021 Q4
5 quarters
|
|
229
Lockheed Martin
LMT
$126B
| $18.9K | 0.01% |
40
| – | – |
2022 Q1
4 quarters
|
|
230
ConocoPhillips
COP
$173B
| $18.9K | 0.01% |
190
| – | – |
2021 Q4
5 quarters
|
|
231
iShares S&P 100 ETF
OEF
$20.6B
| $18.7K | 0.01% |
100
-40
| -29% | -$7.18K |
2021 Q4
5 quarters
|
|
232
Invesco S&P 500 Equal Weight ETF
RSP
$98.6B
| $18.1K | 0.01% |
+125
| New | +$18.3K |
2023 Q1
0 quarters
|
|
233
Teva Pharmaceutical Industries Limited
TEVA
$48.5B
| $18K | 0.01% |
2,036
| – | – |
2022 Q3
2 quarters
|
|
234
Vanguard Tax-Exempt Bond Index Fund
VTEB
$50.4B
| $17.7K | 0.01% |
350
+178
| +103% | +$8.94K |
2021 Q4
5 quarters
|
|
235
Vanguard Extended Market ETF
VXF
$30B
| $17.7K | 0.01% |
+126
| New | +$17.9K |
2023 Q1
0 quarters
|
|
236
Thermo Fisher Scientific
TMO
$256B
| $17.3K | 0.01% |
30
| – | – |
2022 Q1
4 quarters
|
|
237
Alliant Energy
LNT
$17.6B
| $17.1K | 0.01% |
320
| – | – |
2021 Q4
5 quarters
|
|
238
BlackLine
BL
$1.76B
| $16.8K | 0.01% |
250
| – | – |
2022 Q1
4 quarters
|
|
239
Tactile Systems Technology
TCMD
$524M
| $16.4K | 0.01% |
1,000
| – | – |
2022 Q3
2 quarters
|
|
240
lululemon athletica
LULU
$11.6B
| $16.4K | 0.01% |
45
| – | – |
2022 Q1
4 quarters
|
|
|
RRTS
241
DELISTED
RoadRunner Transportation Systems, Inc.
RRTS
| $16K | 0.01% |
8,900
| – | – |
2021 Q4
5 quarters
|
|
242
Vanguard Morningstar Mid-Cap ETF
VO
$107B
| $15.2K | 0.01% |
288
+96
| +50% | +$5.11K |
2022 Q2
3 quarters
|
|
243
Edwards Lifesciences
EW
$50.7B
| $15.1K | 0.01% |
183
| – | – |
2021 Q4
5 quarters
|
|
244
DELISTED
Walgreens Boots Alliance
WBA
| $14.6K | 0.01% |
423
| – | – |
2022 Q1
4 quarters
|
|
245
AstraZeneca
AZN
$259B
| $14.6K | 0.01% |
105
| – | – |
2021 Q4
5 quarters
|
|
246
Schwab U.S Small- Cap ETF
SCHA
$21.6B
| $14.3K | 0.01% |
680
| – | – |
2021 Q4
5 quarters
|
|
247
Conagra Brands
CAG
$6.86B
| $13.7K | 0.01% |
364
| – | – |
2022 Q3
2 quarters
|
|
248
Workday
WDAY
$46.2B
| $13.4K | 0.01% |
+65
| New | +$11.8K |
2023 Q1
0 quarters
|
|
249
VanEck Gold Miners ETF
GDX
$26.4B
| $13.3K | 0.01% |
410
| – | – |
2022 Q4
1 quarter
|
|
250
Barrick Mining
B
$67.3B
| $13K | 0.01% |
700
| – | – |
2022 Q3
2 quarters
|
|
Similar funds
MADR
CPW
PDIP
BP
DAC
PIN
MWC
GS
Operose Advisors's Q1 2023 Portfolio in Review
As of Q1 2023, Operose Advisors held 399 positions worth $201M, up 7.5% from $187M the previous quarter. Its ten largest holdings account for 73% of the portfolio.
Operose Advisors deployed $10.1M of net new capital in Q1 2023, opening 39 new positions and adding to 61 existing holdings. Its largest new stake was Hilton Worldwide: 700 shares worth $98.6K.
By sector, the portfolio is most concentrated in Miscellaneous at 87% of assets, down from 87% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $1.83M trimmed.
- Operose Advisors's largest Q1 2023 buy was Hilton Worldwide: 700 shares worth $98.6K.
- Operose Advisors added most to Vanguard Morningstar Total Stock Market ETF in Q1 2023, an estimated $5.39M increase.
- Operose Advisors's biggest Q1 2023 reduction was iShares National Muni Bond ETF, cutting an estimated $1.83M.
- Operose Advisors fully exited SPDR Gold Trust in Q1 2023, selling an estimated $339K.
- Operose Advisors's ten largest holdings make up 73% of its $201M portfolio in Q1 2023.
- Operose Advisors opened 39 new positions and closed 55 in Q1 2023.
- Operose Advisors's portfolio value rose 7.5% quarter-over-quarter to $201M.
Based on Operose Advisors's 13F filing for Q1 2023, filed 9 May 2023.